share_log

南新制药(688189.SH):2023年净利润预盈1000万元

Nanxin Pharmaceutical (688189.SH): 2023 net profit pre-profit of 10 million yuan

Gelonghui Finance ·  Jan 30 19:11

Gelonghui, January 30丨Nanxin Pharmaceutical (688189.SH) announced the 2023 annual results forecast. According to preliminary estimates by the finance department, it is expected that net profit attributable to owners of the parent company in 2023 will turn a loss into a profit compared with the same period last year, and achieve net profit attributable to the owners of the parent company of 200,000 yuan to 10 million yuan. The net profit attributable to the owners of the parent company after deducting non-recurring profit and loss for the year 2023 is expected to be -5 million yuan to 5 million yuan.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment